Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xtransgenic-Alzheimer's disease mice

Endocrinology

Volumn 151, Issue 6, 2010, Pages 2713-2722

  Carroll, Jenna C ^a   Rosario, Emily R ^a   Villamagna, Angela ^a   Pike, Christian J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ESTRADIOL; PROGESTERONE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS PROGESTERONE TREATMENT; CONTROLLED STUDY; CYCLIC PROGESTERONE TREATMENT; DRUG EFFICACY; FEMALE; FORCED SWIMMING TEST; HIPPOCAMPUS; HORMONAL THERAPY; HORMONE RECEPTOR INTERACTION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAZE TEST; MOUSE; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; THERAPY EFFECT; TRANSGENIC MOUSE; VISUAL ACUITY; WORKING MEMORY; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; DRUG ADMINISTRATION; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; FEMALE; IMMUNOHISTOCHEMISTRY; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVARIECTOMY; PHOSPHORYLATION; PROGESTERONE; TAU PROTEINS;

EID: 77954460733     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1487     Document Type: Article

References (73)

1. Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MMB 2001 Incidence of dementia: does gender make a difference? Neurobiol Aging 22:575-580
2. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A 1999 Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. Neurology 53:1992-1997
3. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D'Agostino RB, White LR 1992 Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 42:115-119
4. Jorm AF, Korten AE, Henderson AS 1987 The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76:465-479
5. Henderson VW 2008 Cognitive changes after menopause: influence of estrogen. Clin Obstet Gynecol 51:618-626
6. Pinkerton JV, Henderson VW 2005 Estrogen and cognition, with a focus on Alzheimer's disease. Semin Reprod Med 23:172-179
7. Paganini-Hill A, Henderson VW 1996 Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 156:2213-2217 (Pubitemid 26361914)
8. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG 1994 Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 51:896-900
9. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E 1997 A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 48:1517-1521
10. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R 1996 Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432
11. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JCS 2002 Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288:2123-2129
12. Waring SC, Rocca WA, Petersen RC, O'Brien PC, Tangalos EG, Kokmen E 1999 Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology 52:965-970
13. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH 2004 Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291:2947-2958
14. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J 2004 Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291:2959-2968
15. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones 3rd BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662
16. Resnick SM, Henderson VW 2002 Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 288:2170-2172
17. Couzin J 2003 Estrogen research. The great estrogen conundrum. Science 302:1136-1138
18. Gibbs RB, Gabor R 2003 Estrogen and cognition: applying preclinical findings to clinical perspectives. J Neurosci Res 74:637-643
19. Brinton RD 2004 Impact of estrogen therapy on Alzheimer's disease: a fork in the road? CNS Drugs 18:405-422
20. Craig MC, Maki PM, Murphy DG 2005 The Women's Health Initiative Memory Study: findings and implications for treatment. Lancet Neurol 4:190-194
21. Pike CJ, Carroll JC, Rosario ER, Barron AM 2009 Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol 30:239-258
22. Toran-Allerand CD 2006 Hormone in the hot seat. Nat Med 12:379-380 (Reply)
23. Lee SJ, McEwen BS 2001 Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 41:569-591
24. Green PS, Simpkins JW 2000 Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18:347-358
25. Wise PM 2002 Estrogens and neuroprotection. Trends Endocrinol Metab 13:229-230
26. Schumacher M, Sitruk-Ware R, De Nicola AF 2008 Progesterone and progestins: neuroprotection and myelin repair. Curr Opin Pharmacol 8:740-746
27. Brinton RD, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, Morgan TE, Pike CJ, Mack WJ, Stanczyk FZ, Nilsen J 2008 Progesterone receptors: form and function in brain. Front Neuroendocrinol 29:313-339
28. Gibbs RB 2000 Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 101:931-938
29. Bimonte-Nelson HA, Francis KR, Umphlet CD, Granholm AC 2006 Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle-aged ovariectomized female rats. Eur J Neurosci 24:229-242
30. Bimonte-Nelson HA, Nelson ME, Granholm AC 2004 Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain. Neuroreport 15:2659-2663
31. Rosario ER, Ramsden M, Pike CJ 2006 Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus. Brain Res 1099:206-210
32. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ 2007 Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 27:13357-13365
33. Hardy J, Selkoe DJ 2002 The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356
34. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D 1995 Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85:304-313
35. Whitehead MI, Hillard TC, Crook D 1990 The role and use of progestogens. Obstet Gynecol 75:59S-76S; discussion 81S-83S
36. PEPI Writing Group 1995 Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 273:199-208
37. Castelo-Branco C, Figueras F, Sanjuan A, Pons F, Vicente JJ, Vanrell JA 1999 Long-term postmenopausal hormone replacement therapy effects on bone mass: differences between surgical and spontaneous patients. Eur J Obstet Gynecol Reprod Biol 83:207-211
38. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM 2003 Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39:409-421
39. Carroll JC, Pike CJ 2008 Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology 149:2607-2611
40. Harmon RL, Sugarbaker PH 2005 Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2:3
41. Henderson VW 2009 Estrogens, episodic memory, and Alzheimer's disease: a critical update. Sem Reprod Med 27:283-293
42. Miller VM, Black DM, Brinton EA, Budoff MJ, Cedars MI, Hodis HN, Lobo RA, Manson JE, Merriam GR, Naftolin F, Santoro N, Taylor HS, Harman SM 2009 Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Trans Res 2:228-239
43. Carroll JC, Boyce-Rustay JM, Millstein R, Yang R, Wiedholz LM, Murphy DL, Holmes A 2007 Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav Genet 37:214-222
44. Boyce-Rustay JM, Holmes A 2006 Genetic inactivation of the NMDAreceptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 31:2405-2414
45. Frye CA, Sumida K, Dudek BC, Harney JP, Lydon JP, O'Malley BW, Pfaff DW, Rhodes ME 2006 Progesterone's effects to reduce anxiety behavior of aged mice do not require actions via intracellular progestin receptors. Psychopharmacology (Berl) 186:312-322
46. Frye CA, Wawrzycki J 2003 Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm Behav 44:319-326
47. Roof RL, Duvdevani R, Braswell L, Stein DG 1994 Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 129:64-69
48. Stein DG, Hoffman SW 2003 Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil 6:13-22
49. Labombarda F, Gonzalez SL, Deniselle MC, Vinson GP, Schumacher M, DeNicola AF, Guennoun R 2003 Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord. J Neurochem 87:902-913
50. Cervantes M, González-Vidal MD, Ruelas R, Escobar A, Moralí G 2002 Neuroprotective effects of progesterone on damage elicited by acute global cerebral ischemia in neurons of the caudate nucleus. Arch Med Res 33:6-14
51. Gibson CL, Constantin D, Prior MJ, Bath PM, Murphy SP 2005 Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol 193:522-530
52. Garay L, Deniselle MC, Meyer M, Costa JJ, Lima A, Roig P, De nicola AF 2009 Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis. Brain Res 1283:177-185
53. Ciriza I, Carrero P, Frye CA, Garcia-Segura LM 2006 Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. J Neurobiol 66:916-928
54. Rhodes ME, Frye CA 2004 Progestins in the hippocampus of female rats have antiseizure effects in a pentylenetetrazole seizure model. Epilepsia 45:1531-1538
55. Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ 2006 Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci 26:13384-13389
56. Frick KM, Fernandez SM, Bulinski SC 2002 Estrogen replacement improves spatial reference memory and increases hippocampal synaptophysin in aged female mice. Neuroscience 115:547-558
57. Gibbs RB, Hashash A, Johnson DA 1997 Effects of estrogen on potassium-stimulated acetylcholine release in the hippocampus and overlying cortex of adult rats. Brain Res 749:143-146
58. Gibbs RB 1996 Fluctuations in relative levels of choline acetyltransferase mRNA in different regions of the rat basal forebrain across the estrous cycle: effects of estrogen and progesterone. J Neurosci 16:1049-1055
59. Frye CA, Walf AA 2008 Effects of progesterone administration and APPswe+PSEN1Δe9 mutation for cognitive performance of mid-aged mice. Neurobiol Learn Mem 89:17-26
60. Frye CA, Walf AA 2009 Progesterone reduces depression-like behavior in a murine model of Alzheimer's Disease. Age (Dordr) 31:143-153
61. Gibbs RB, Nelson D, Anthony MS, Clarkson TB 2002 Effects of long-term hormone replacement and of tibolone on choline acetyltransferase and acetylcholinesterase activities in the brains of ovariectomized, cynomolgus monkeys. Neuroscience 113:907-914
62. D'Andrea MR, Nagele RG 2006 Targeting the α7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. Curr Pharm Des 12:677-684
63. Jayaraman A, Pike CJ 2009 Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in cultured neurones. J Neuroendocrinol 21:77-81
64. Aguirre CC, Baudry M 2009 Progesterone reverses 17β-estradiol- mediated neuroprotection and BDNF induction in cultured hippocampal slices. Eur J Neurosci 29:447-454
65. Yamada K, Tanaka T, Zou LB, Senzaki K, Yano K, Osada T, Ana O, Ren X, Kameyama T, Nabeshima T 1999 Long-term deprivation of oestrogens by ovariectomy potentiates β-amyloid-induced working memory deficits in rats. Br J Pharmacol 128:419-427
66. McLaughlin KJ, Bimonte-Nelson H, Neisewander JL, Conrad CD 2008 Assessment of estradiol influence on spatial tasks and hippocampal CA1 spines: evidence that the duration of hormone deprivation after ovariectomy compromises 17β-estradiol effectiveness in altering CA1 spines. Horm Behav 54:386-395
67. Miller MM, Hyder SM, Assayag R, Panarella SR, Tousignant P, Franklin KB 1999 Estrogen modulates spontaneous alternation and the cholinergic phenotype in the basal forebrain. Neuroscience 91:1143-1153
68. Walf AA, Koonce C, Manley K, Frye CA 2009 Proestrous compared to diestrous wildtype, but not estrogen receptor β knockout, mice have better performance in the spontaneous alternation and object recognition tasks and reduced anxiety-like behavior in the elevated plus and mirror maze. Behav Brain Res 196:254-260
69. Woolley CS, McEwen BS 1993 Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 336:293-306
70. Strom JO, Theodorsson A, Theodorsson E 2009 Dose-related neuroprotective versus neurodamaging effects of estrogens in rat cerebral ischemia: a systematic analysis. J Cereb Blood Flow Metab 29:1359-1372
71. Ström JO, Theodorsson E, Theodorsson A 2008 Order of magnitude differences between methods for maintaining physiological 17β-oestradiol concentrations in ovariectomized rats. Scand J Clin Lab Invest 68:814-822
72. Theodorsson A, Hilke S, Rugarn O, Linghammar D, Theodorsson E 2005 Serum concentrations of 17β-estradiol in ovariectomized rats during two times six weeks crossover treatment by daily injections in comparison with slow-release pellets. Scand J Clin Lab Invest 65:699-705
73. Rozovsky I, Hoving S, Anderson CP, O'Callaghan J, Finch CE 2002 Equine estrogens induce apolipoprotein E and glial fibrillary acidic protein in mixed glial cultures. Neurosci Lett 323:191-194